Literature DB >> 32506456

A prospective, multicentre study in acute noncirrhotic, nonmalignant portal vein thrombosis: comparison of medical and interventional treatment.

Martin Rössle1, Dominik Bettinger1, Jonel Trebicka2,3, Christoph Klinger4, Michael Praktiknjo2, Lukas Sturm1, Karel Caca4, Victoria Therese Mücke3, Klaus Radecke5, Cornelius Engelmann6, Alexander Zipprich7, Hauke Heinzow8, Carsten Meyer2, Ulrich Tappe9, Beate Appenrodt10, Arthur Schmidt1, Christian Lange3,11, Christian Strassburg2, Stefan Zeuzem3, Daniel Grandt5, Hartmut Schmidt8, Joachim Moessner6, Thomas Berg6, Frank Lammert10, Robert Thimme1, Michael Schultheiß1.   

Abstract

BACKGROUND: To evaluate medical versus interventional treatment (transjugular thrombus fragmentation, local thrombolysis with or without stent implantation) in patients with acute noncirrhotic, nonmalignant portal vein thrombosis (PVT).
METHODS: This prospective, observational study enrolled 65 patients with acute (<28 days since begin of symptoms, no cavernoma) PVT in nine centres. Thirty patients received medical treatment and 35 patients received interventional treatment. PVT was graded into grade 1: short thrombosis and incomplete occlusion of the vessel lumen and grade 2: extended thrombosis or complete occlusion. Treatment response was classified as partial or complete, if thrombosis was reduced by one grade or to <25% of the vessel diameter respectively.
RESULTS: Partial and complete response rates were 7% and 30% in the medical compared to 17% and 54% (P < 0.001) in the interventional treatment group. In the multivariate analysis, interventional treatment showed a strong positive (OR 4.32, P < 0.016) and a myeloproliferative aetiology a negative (OR 0.09, P = 0.006) prediction of complete response. Complications were rare in the medical group and consisted of septicaemia and upper gastrointestinal bleeding of unknown origin in one patient each. Interventional treatment was accompanied by mild and self-limiting bleeding complications in nine patients, moderate intra-abdominal bleeding requiring transfusions (2 units) in one patient and peritoneal bleeding requiring surgical rescue in one patient. Four patients in each group developed intestinal gangrene requiring surgery. One patient died 52 days after unsuccessful interventional treatment.
CONCLUSIONS: Compared to medical treatment alone, interventional treatment doubled response rates at the cost of increased bleeding complications.
© 2020 The Authors. Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.

Entities:  

Year:  2020        PMID: 32506456     DOI: 10.1111/apt.15811

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

Review 1.  Imaging-guided interventions modulating portal venous flow: Evidence and controversies.

Authors:  Roberto Cannella; Lambros Tselikas; Fréderic Douane; François Cauchy; Pierre-Emmanuel Rautou; Rafael Duran; Maxime Ronot
Journal:  JHEP Rep       Date:  2022-04-04

2.  Direct oral anticoagulants for unusual-site venous thromboembolism.

Authors:  Nicoletta Riva; Walter Ageno
Journal:  Res Pract Thromb Haemost       Date:  2021-01-28

3.  Validation of color Doppler ultrasound and computed tomography in the radiologic assessment of non-malignant acute splanchnic vein thrombosis.

Authors:  Lukas Sturm; Dominik Bettinger; Christoph Klinger; Tobias Krauss; Hannes Engel; Jan Patrick Huber; Arthur Schmidt; Karel Caca; Robert Thimme; Michael Schultheiss
Journal:  PLoS One       Date:  2021-12-20       Impact factor: 3.240

4.  Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access.

Authors:  Nabeel Mansour; Osman Öcal; Mirjam Gerwing; Michael Köhler; Sinan Deniz; Hauke Heinzow; Christian Steib; Martin K Angele; Max Seidensticker; Jens Ricke; Moritz Wildgruber
Journal:  Abdom Radiol (NY)       Date:  2022-01-12

5.  Percutaneous Transsplenic Balloon-Assisted Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Portal Vein Obliteration for Portal Vein Recanalization: Feasibility, Safety and Effectiveness.

Authors:  T C Meine; L S Becker; C L A Dewald; S K Maschke; B Maasoumy; E Jaeckel; H Wedemeyer; F K Wacker; B C Meyer; J B Hinrichs
Journal:  Cardiovasc Intervent Radiol       Date:  2022-01-11       Impact factor: 2.797

6.  Successful treatment of acute symptomatic extensive portal venous system thrombosis by 7-day systemic thrombolysis.

Authors:  Fang-Bo Gao; Le Wang; Wen-Xiu Zhang; Xiao-Dong Shao; Xiao-Zhong Guo; Xing-Shun Qi
Journal:  World J Gastrointest Surg       Date:  2022-09-27

Review 7.  [Portal vein thrombosis-treatment options].

Authors:  C Steib; M Guba; M Seidensticker
Journal:  Gastroenterologe       Date:  2021-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.